In vitro investigation of the genotoxicity of portimine, a cyclic imine toxin produced by the dinoflagellate Vulcanodinium rugosum, on human hepatic HepaRG cells.


Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 10 12 2020
revised: 29 01 2021
accepted: 18 02 2021
pubmed: 26 2 2021
medline: 9 11 2021
entrez: 25 2 2021
Statut: ppublish

Résumé

Portimine, a recently identified cyclic imine produced by the dinoflagellate Vulcanodinium rugosum, has been described as a potent apoptotic agent in contrast to most of the cyclic imines that are well-known to be neurological toxins. As apoptosis can be a consequence of a high level of DNA lesions, we investigated the responses of portimine on several endpoints aimed at detecting DNA damage in the hepatic cell line HepaRG. Portimine induced phosphorylation of H2AX, which could possibly be consistent with the previously published induction of apoptosis with this toxin. In addition, detection of apoptosis through the activation of caspase-3, the induction of strand breaks detected by the comet assay as well as chromosome and genome mutations using the micronucleus assay were addressed. Surprisingly, portimine treatment resulted in increases in only γH2AX in differentiated HepaRG cells whereas no effects on the other endpoints were detected. These increases in γH2AX in the absence of genotoxic effects in the other tests could indicate that portimine could possibly induce a DNA replication stress and/or that the compound can be detoxified by the HepaRG cells.

Identifiants

pubmed: 33631200
pii: S0887-2333(21)00050-3
doi: 10.1016/j.tiv.2021.105125
pii:
doi:

Substances chimiques

H2AX protein, human 0
Histones 0
Imines 0
Marine Toxins 0
Spiro Compounds 0
portimine 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105125

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Kevin Hogeveen (K)

Agence Nationale de Sécurité Sanitaire (ANSES), Unité de Toxicologie des Contaminants, 10 B rue Claude Bourgelat, 35306 Fougères, France; ASPIC Cellular Imaging Platform, 10B rue C. Bourgelat, 35306 Fougères, France.

Sylvie Huet (S)

Agence Nationale de Sécurité Sanitaire (ANSES), Unité de Toxicologie des Contaminants, 10 B rue Claude Bourgelat, 35306 Fougères, France.

Charlène Besnard (C)

Agence Nationale de Sécurité Sanitaire (ANSES), Unité de Toxicologie des Contaminants, 10 B rue Claude Bourgelat, 35306 Fougères, France.

J Sam Murray (JS)

Cawthron Institute, Private Bag 2, Nelson, New Zealand.

D Tim Harwood (DT)

Cawthron Institute, Private Bag 2, Nelson, New Zealand.

Andy I Selwood (AI)

Cawthron Institute, Private Bag 2, Nelson, New Zealand.

Valérie Fessard (V)

Agence Nationale de Sécurité Sanitaire (ANSES), Unité de Toxicologie des Contaminants, 10 B rue Claude Bourgelat, 35306 Fougères, France. Electronic address: valerie.fessard@anses.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH